Neonatal Intensive Care Unit, "Bambino Gesù" Children's Hospital IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy.
PhD Course in Microbiology, Immunology, Infectious Diseases and Transplants (MIMIT), University of Rome "Tor Vergata", Rome, Italy.
Eur J Pediatr. 2023 Nov;182(11):4859-4866. doi: 10.1007/s00431-023-05144-4. Epub 2023 Aug 16.
Changes in the organization of the clinical care wards, requested by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic, have influenced the environmental circulation of other pathogens. The implementation of prevention procedures may have led to a decrease in the incidence of healthcare-associated infections. We aimed to investigate the impact of prevention and control measures for preventing the COVID-19 spread on the incidence of bacterial sepsis and invasive fungal infections in neonates and infants requiring major surgery. We compared the incidence of bacterial and fungal sepsis and their risk factors observed before the SARS-CoV-2 pandemic (from 01/10/2018 to 29/02/2020) with those observed during the pandemic (from 01/03/2020 to 07/05/2021) in 13 level III Neonatal Intensive Care Units in Italy, through a secondary analysis of data, collected during a prospective multicenter study (REF). The patients enrolled were infants within three months of life, hospitalized in the two periods in the participating centers to undergo major surgery. Among 541 enrolled patients, 324 (59.9%) were born in the pre-pandemic period and 217 (40.1%) during the pandemic. The incidence density (ID) of any infection in the pre-pandemic period was 16.0/1000 patient days versus 13.6/1000 patient days in the pandemic period (p < 0.001). One hundred and forty-five (145/324; 44.8%) patients developed at least one episode of bacterial sepsis in the pre-pandemic period, versus 103/217 (31.8%) patients, during the pandemic (p = 0.539). Concerning fungal sepsis, 12 (3.7%) patients had one episode in the pre-pandemic period versus 11 (5.1%) patients during the pandemic (p = 0.516). The most significant differences observed in the use of healthcare procedures were the reduction of CVC days, the reduced use of antibiotics pre-surgery, and that of proton pump inhibitors during the SARS-CoV-2 pandemic compared with the previous period.
In our cohort of patients with major surgical needs, the reduction of CVC days, pre-surgery antibiotics administration, and current use of proton pump inhibitors, during the SARS-CoV-2 pandemic, led to a decrease in the incidence of late-onset sepsis.
• Most cases of late-onset sepsis in neonates are referred to as central line-associated bloodstream infections. • In adults, the COVID-19 outbreak negatively influenced healthcare-associated infection rates and infection clusters within hospitals.
• In neonates and infants undergoing major surgery the incidence density of infections was lower in the pandemic period than before. • The most significant differences observed in the use of healthcare procedures were the reduction of CVC days, the reduced use of antibiotics before surgery, and that of proton pump inhibitors during the pandemic compared with previously.
调查预防和控制 COVID-19 传播的措施对需要大手术的新生儿和婴儿中细菌性败血症和侵袭性真菌感染发生率的影响。
通过对意大利 13 个三级新生儿重症监护病房进行的数据进行二次分析,比较了在 SARS-CoV-2 大流行(2020 年 3 月 1 日至 2021 年 5 月 7 日)之前(2018 年 10 月 1 日至 2020 年 2 月 29 日)和大流行期间(2020 年 3 月 1 日至 2021 年 5 月 7 日)观察到的细菌性和真菌性败血症的发生率及其危险因素。REF)中前瞻性多中心研究收集的数据。
在参加中心住院接受大手术的三个月内出生的婴儿。在 541 名入组患者中,324 名(59.9%)出生于大流行前,217 名(40.1%)出生于大流行期间。大流行前时期的任何感染发生率密度(ID)为 16.0/1000 患者天,大流行期间为 13.6/1000 患者天(p<0.001)。在大流行前时期,有 145/324(44.8%)名患者发生了至少一次细菌性败血症发作,而在大流行期间,有 103/217(31.8%)名患者发生了细菌性败血症发作(p=0.539)。在真菌性败血症方面,大流行前时期有 12 名(3.7%)患者发生了一次,而大流行期间有 11 名(5.1%)患者发生了一次(p=0.516)。与前一时期相比,在大流行期间观察到的医疗程序使用方面的最大差异是 CVC 天数减少、手术前抗生素使用减少和质子泵抑制剂使用减少。
在我们需要大手术的患者队列中,与前一时期相比,在大流行期间减少 CVC 天数、手术前使用抗生素和目前使用质子泵抑制剂导致了晚发性败血症发生率的降低。
• 大多数新生儿晚发性败血症病例被认为是中心静脉导管相关血流感染。• 在成人中,COVID-19 疫情对医院内与医疗保健相关的感染率和感染群产生了负面影响。
• 在接受大手术的新生儿和婴儿中,大流行期间的感染发生率密度低于大流行前。• 与前一时期相比,在医疗程序的使用方面观察到的最大差异是 CVC 天数减少、手术前抗生素使用减少以及大流行期间质子泵抑制剂的使用减少。